Acetylsalicylic acid inhibits proliferation of human bone marrow stromal cells and matrix mineralization

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 4, 2008, Pages 921-928

  Guida, L ^a   Annunziata, M ^a   Passaro, I ^a   Buonaiuto, C ^a   Rullo, R ^a   Tete S ^b   Della Ragione, F ^a   Oliva, Adriana ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Acetylsalicylic acid; Bone marrow stromal cells; Osteogenic differentiation; Proliferation

Indexed keywords

ACETYLSALICYLIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MINERALIZATION; CALCIUM CELL LEVEL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS INHIBITION; ENZYME ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STROMA CELL;

EID: 59849085813     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100416     Document Type: Article

References (27)

1. Trevor AJ, Katzung BG, Masters SB. Katzung & Trevor's Review of Pharmacology, 2002, 6th Edition, McGraw-Hill, 322-329.
2. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998; 38:97-120.
3. Vuolteenaho K, Moilanen T, Moilanen E. Nonsteroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process. Basic Clin Pharmacol Toxicol 2008; 102:10-4.
4. Harder AT, An YH. The mechanisms of the inhibitory effects of nonsteroidal anti-inflammatory drugs on bone healing: a concise review. J Clin Pharmacol 2003; 43:807-15.
5. Fransen M, Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database of Systematic Reviews 2004, Issue 2.
6. Trancik T, Mills W, Vinson N. The effect of indomethacin, aspirin, and ibuprofen on bone ingrowth into a porous-coated implant. Clin Orthop Relat Res 1989; 249:113-21.
7. Baratieri A, Deli R. The effect on bone repair of aspirin cones placed in extraction sockets in dogs: a histopathologic study. J Oral Pathol 1979; 8:198-206.
8. Ho ML, Chang JK, Chuang LY, Hsu HK, Wang GJ. Effects of nonsteroidal anti-inflammatory drugs and prostaglandins on osteoblastic functions. Biochem Pharmacol 1999; 58:983-90.
9. Chang JK, Wang GJ, Tsai ST, Ho ML. Nonsteroidal anti-inflammatory drug effects on osteoblastic cell cycle, cytotoxicity, and cell death. Connect Tissue Res 2005; 46:200-10.
10. Evans CE, Butcher C. The influence on human osteoblasts in vitro of non-steroidal anti-inflammatory drugs which act on different cyclooxygenase enzymes. J Bone Joint Surg 2004; 86:444-9.
11. Khokher MA, Dandona P. The effect of indomethacin and aspirin on alkaline phosphatase secretion and [3H]thymidine incorporation by human osteoblasts. Br J Rheumatol 1988; 27:291-4.
12. Pearce HR, Kalia N, Bardhan KD, Brown NJ. Effects of aspirin and indomethacin on endothelial cell proliferation in vitro. J Gastroenterol Hepatol 2003; 19: 1180-7.
13. Gao J, Niwa K, Sun W, Takemura M, Lian Z, Onogi K, Seishima M, Mori H, Tamaya T. Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci 2004; 95: 901-7.
14. Goel A, Chang DK, Ricciardiello L, Gasche C, Boland CR. A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells. Clin Cancer Res 2003; 9:383-90.
15. Wang Y, Chen X, Zhu W, Zhang H, Hu S, Cong X. Growth inhibition of mesenchymal stem cells by aspirin: involvement of the WNT/beta-catenin signal pathway. Clin Exp Pharmacol Physiol 2006; 33:696-701.
16. Oliva A, Passaro I, Di Pasquale R, et al. Ex vivo expansion of bone marrow mesenchymal stem cells by platelet-rich plasma. Int J Immunopathol Pharmacol 2005; 3(S):47-53.
17. Della Ragione F, Cucciolla V, Criniti V, Stefania Indaco S, Borriello A, Zappia V. p21Cip1 gene expression is modulated by Egrl. J Biol Chem 2003; 278:23360-23368.
18. Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest 1975; 56: 624-32.
19. Lecomte M, Laneuville O, Ji C, DeWitt DL, Smith WL. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem 1994; 269:13 207-15.
20. Simon AM, Manigrasso MB, O'Connor JP. Cycleoxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002; 17:963-76.
21. Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn TA. Differential inhibition of fracture healing by nonselective and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs. J Orthop Res 2003; 21:670-5.
22. Raisz LG. Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J Nutr 1995; 125:2024-7.
23. Weinreb M, Grosskopf A, Shir N. The anabolic effect of PGE2 in rat bone marrow cultures is mediated via the EP4 receptor subtype. Am J Physiol 1999; 276: 376-83.
24. Kaneki H, Takasugi I, Fujieda M, Kirin M, Mizuochi S, Ide H. Prostaglandin E2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts. J Cell Biochem 1999; 73:36-48.
25. Tang LY, Kimmel DB, Jee WS, Yee JA. Functional characterization of prostaglandin E2 inducible osteogenic colony forming units in cultures of cells isolated from the neonatal rat calvarium. J Cell Physiol 1996; 166:76-83.
26. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002; 109:1405-15.
27. Rosenquist JB, Ohlin A, Lerner UH. Cytokine-induced inhibition of bone matrix proteins is not mediated by prostaglandins. Inflamm Res 1996; 45:457-63.